FI910653A0 - Syntetiska receptoranaloger - Google Patents

Syntetiska receptoranaloger

Info

Publication number
FI910653A0
FI910653A0 FI910653A FI910653A FI910653A0 FI 910653 A0 FI910653 A0 FI 910653A0 FI 910653 A FI910653 A FI 910653A FI 910653 A FI910653 A FI 910653A FI 910653 A0 FI910653 A0 FI 910653A0
Authority
FI
Finland
Prior art keywords
pct
galabiose
synthetic receptor
receptor analogs
sec
Prior art date
Application number
FI910653A
Other languages
English (en)
Finnish (fi)
Other versions
FI93016C (sv
FI93016B (sv
Inventor
Hans Goeran Magnusson
Jan Olof Kihlberg
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbicom Ab filed Critical Symbicom Ab
Publication of FI910653A0 publication Critical patent/FI910653A0/sv
Application granted granted Critical
Publication of FI93016B publication Critical patent/FI93016B/sv
Publication of FI93016C publication Critical patent/FI93016C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/14Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI910653A 1988-08-12 1991-02-11 Syntetiska receptoranaloger FI93016C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK455088 1988-08-12
DK455088A DK455088D0 (da) 1988-08-12 1988-08-12 Syntetiske receptoranaloger
PCT/DK1989/000192 WO1990001488A1 (en) 1988-08-12 1989-08-11 Synthetic receptor analogues
DK8900192 1989-08-11

Publications (3)

Publication Number Publication Date
FI910653A0 true FI910653A0 (sv) 1991-02-11
FI93016B FI93016B (sv) 1994-10-31
FI93016C FI93016C (sv) 1995-02-10

Family

ID=8134551

Family Applications (1)

Application Number Title Priority Date Filing Date
FI910653A FI93016C (sv) 1988-08-12 1991-02-11 Syntetiska receptoranaloger

Country Status (12)

Country Link
US (1) US5474986A (sv)
EP (1) EP0428605B1 (sv)
JP (1) JPH04506509A (sv)
KR (1) KR900701807A (sv)
AT (1) ATE113056T1 (sv)
AU (1) AU634976B2 (sv)
CA (1) CA1332234C (sv)
DE (1) DE68918944T2 (sv)
DK (1) DK455088D0 (sv)
FI (1) FI93016C (sv)
IL (1) IL91269A (sv)
WO (1) WO1990001488A1 (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4119472A1 (de) * 1991-06-13 1992-12-17 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von gal-(alpha)(1-3)/gal-(beta)(1-4)/glcnac-trisacchariden und von neuen (beta)(1-3)-verknuepften oligolactosaminen ueber neue partiell alkylierte glykale
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
EP0601417A3 (de) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
TW307775B (en) * 1994-02-15 1997-06-11 Novartis Erfind Verwalt Gmbh Unsaturated carbohydrate derivatives, polymers thereof and their use
US6596707B2 (en) * 2001-05-24 2003-07-22 Abbott Laboratories Monovalent saccharides and uses thereof
US7790010B2 (en) * 2002-12-20 2010-09-07 University Of Maryland, College Park Spatially selective deposition of polysaccharide layer onto patterned template
WO2005055944A2 (en) * 2003-12-05 2005-06-23 Cincinnati Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
JP5766947B2 (ja) 2007-09-07 2015-08-19 チルドレンズ ホスピタル メディカル センター 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
EP3248605A1 (en) 2009-07-06 2017-11-29 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
JP6187893B2 (ja) * 2011-07-08 2017-08-30 群栄化学工業株式会社 保湿剤の製造方法
WO2014130789A1 (en) 2013-02-21 2014-08-28 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
WO2019133878A1 (en) 2017-12-29 2019-07-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CA3122321A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Galectin-3 inhibiting c-glycosides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
SE8304007D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater

Also Published As

Publication number Publication date
JPH04506509A (ja) 1992-11-12
AU4074989A (en) 1990-03-05
US5474986A (en) 1995-12-12
DE68918944T2 (de) 1995-05-11
FI93016C (sv) 1995-02-10
IL91269A (en) 1994-11-11
DK455088D0 (da) 1988-08-12
EP0428605A1 (en) 1991-05-29
EP0428605B1 (en) 1994-10-19
DE68918944D1 (de) 1994-11-24
KR900701807A (ko) 1990-12-04
ATE113056T1 (de) 1994-11-15
FI93016B (sv) 1994-10-31
CA1332234C (en) 1994-10-04
WO1990001488A1 (en) 1990-02-22
AU634976B2 (en) 1993-03-11

Similar Documents

Publication Publication Date Title
DK455088D0 (da) Syntetiske receptoranaloger
ES2131496T3 (es) Mejoras relativas a derivados glicopeptidicos.
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
MY129994A (en) Novel siloxane derivatives, producing method thereof and agents including siloxane derivative
TW263423B (sv)
SE8503680D0 (sv) Indolderivat
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
DK0465581T3 (da) Erythromycinderivater
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
ES2028871T3 (es) Un procedimiento para la preparacion de un glicosido de antraciclina. .
DK218388A (da) Aktivt princip isoleret fra hajvaev
GR3005566T3 (sv)
FI901213A0 (fi) Substituerade (kinolin-2-ylmetoxi) fenyl-n,n'-sulfonylurinaemnen, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE41927T1 (de) Phenylalkylamine - bioregulatoren.
ES2119814T3 (es) Metodo para la separacion de mezclas de gibberelinas.
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
DK0544168T3 (da) Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler
ES273762Y (es) Panal-braguita infantil, perfeccionado.
NO974687L (no) Kondenserte <beta>-carboliner
LT2623B (lt) Pakeistu 1,3,4,9-tetrahidropiran(3,4-beta)indol-1-acto rugsciu arba ju farmaciskai priimtinu drusku gavimo budas

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed